                               SEQUENCE LISTING	

<110> ESCAPE THERAPEUTICS, INC.
 
<120> HYBRID HYDROGEL SCAFFOLD COMPOSITIONS AND METHODS OF USE

<130> 2200876.125WO1

<140> PCT/US11/28638
<141> 2011-03-16

<150> 61/314,265
<151> 2010-03-16

<160> 13    

<170> PatentIn version 3.5

<210> 1
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Lys Phe Glu Phe Lys Phe Glu Phe 
1               5               


<210> 2
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Phe Glu Phe Lys Phe Glu Phe Lys 
1               5               


<210> 3
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Arg Ala Asp Ala Arg Ala Asp Ala 
1               5               


<210> 4
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Arg Ala Arg Ala Asp Ala Asp Ala 
1               5               


<210> 5
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Ala Glu Ala Lys Ala Glu Ala Lys 
1               5               


<210> 6
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Arg Ala Glu Ala Arg Ala Glu Ala 
1               5               


<210> 7
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Lys Ala Asp Ala Lys Ala Asp Ala 
1               5               


<210> 8
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
Ala Glu Ala Glu Ala His Ala His 
1               5               


<210> 9
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
Leu Glu Leu Glu Leu Lys Leu Lys 
1               5               


<210> 10
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
Ala Glu Ala Glu Ala Lys Ala Lys 
1               5               


<210> 11
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
His Glu His Glu His Lys His Lys 
1               5               


<210> 12
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 12
Phe Lys Phe Glu Phe Lys Phe Glu 
1               5               


<210> 13
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 13
Glu Phe Lys Phe Glu Phe Lys Phe 
1               5               


